University of Notre Dame du Lac’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-489,196	Closed	-$1.85M	–	58
2019 Q2	$1.85M	Buy	+489,196	New	+$1.85M	0.42%	56
2017 Q3	–	Sell	-422,767	Closed	-$2.35M	–	74
2017 Q2	$2.35M	Buy	422,767 +100,603	+31%	+$559K	0.69%	67
2017 Q1	$2.71M	Buy	+322,164	New	+$2.71M	0.68%	53